期刊文献+

雷帕霉素治疗结节性硬化症合并婴儿痉挛症一例报告并文献复习 被引量:5

Rapamycin in tuberous sclerosis patient with infantile spasm: a case report and literature review
原文传递
导出
摘要 目的探讨雷帕霉素治疗结节性硬化症合并婴儿痉挛症的临床疗效。方法对解放军总医院儿童医学中心2011年6月收治的1例结节性硬化症合并婴儿痉挛症患儿应用雷帕霉素治疗前后的临床表现、辅助检查方法、治疗结果等进行回顾性分析。结果患儿有明显的皮肤损害,主要表现为色素脱失斑,同时合并婴儿痉挛症,头颅MRI及CT均有异常改变。患儿应用雷帕霉素治疗3个月后可见色素脱失减轻,痉挛发作较前明显减少,头颅MRI显示室管膜下结节较前减小,脑电图较前改善,智能发育进步,且治疗过程中未见明碾不良反应。结论应用雷帕霉素治疗结节性硬化症合并婴儿痉挛症有显著疗效.安全性好。 Objective To analyze the clinical features of tuberous sclerosis (TS) patient with infantile spasm and investigate its treatment efficacy with rapamycin. Methods The clinical manifestations of a tuberous sclerosis patient with infantile spasm before and after the treatment with rapamycin were retrospectively analyzed; and the related literature was reviewed. Results Dermatological abnormalities were evident in the child and mainly shown as hypomelanotic macules. His neurological abnormalities included infantile spasm and backward psychomotor development. Head MRI and CT had abnormal changes. Treatment with rapamycin 3 months later disclosed improvement in many ways: the convulsion seizure of the patient decreased apparently, and MRI showed decreased subependymal tuber size; meanwhile, the intellectual development of the patient improved obviously, and there was no adverse reaction. Conclusion Rapamycin, enjoying good effect, would be a new and safety method to treat TS patients with infantile spasm.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第5期508-511,共4页 Chinese Journal of Neuromedicine
关键词 雷帕霉素:结节性硬化 婴儿痉挛症 Rapamycin Tuberous sclerosis Infantile spasm
  • 相关文献

参考文献18

  • 1Orlova KA, Crino PB. The tuberous sclerosis complex[J]. Ann N Y Acad Sci, 2010, 1184: 87-105.
  • 2Napolioni V, Curatolo P. Genetics and molecular biology of tuberous sclerosis complex [J]. Curt Gcnomics, 2008, 9 (7): 475- 487.
  • 3Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria[J]. J Child Neurol, 1998, 13(12): 624.
  • 4Kwiatkowski DJ. Rhebbing up mTOR: new insights on TSCI and TSC2, and the pathogenesis of tuberous sclerosis[J]. Cancer Biol Ther, 2003, 2(5): 471-476.
  • 5Nobukini T, Thomas G. The mTOR/S6K signaling pathway: the role of the TSCI/2 tumour suppressor complex and the proto-oncogene Rheb [J]. Novartis Found Syrup, 2004, 262: 148-159, 265-268.
  • 6Dasgupta B, Yi Y, Chert DY, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors [J]. Cancer Res, 2005, 65(7): 2755-2760.
  • 7Kenerson H, Dundon TA, Yeung RS. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex[J]. Pediatr Res, 2005, 57(1): 67-75.
  • 8Guba M, Yezhelvev M, Eichhom ME, et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the present of VEGF [J]. Blood, 2005, 105(11): 4463-4469.
  • 9Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of Astrocytomas in Tuberous Sclerosis complex [J]. Ann Neurol, 2006, 59(3): 490-498.
  • 10Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis [J]. N Engl J Med, 2010, 363(19): 1801-1811.

同被引文献28

  • 1沙悦,薛静,张文.结节性硬化多系统损害伴发热误诊1例并文献复习[J].中国误诊学杂志,2004,4(4):489-490. 被引量:1
  • 2赵东菊,张文林,张铭秋.结节性硬化症儿童临床与CT特点[J].实用儿科临床杂志,2007,22(16):1219-1219. 被引量:6
  • 3Holmes GL, Stafstrom CE. The Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy:Recent developments and future challenges[J]. Epilepsia, 2007, 48(4): 617-630.
  • 4Thiele EA. Managing epilepsy in tuberous sclerosis complex [J]. J Child Neurol, 2004, 19(9): 680- 686.
  • 5Petrova LD. Tuberous sclerosis and epilepsy [J]. Am J Electroneurodiagnostic Technol, 201 I, 51(1): 5-15.
  • 6DiMario FG Jr. Brain abnormalities in tuberous sclerosis complex [J]. J Child Neurol, 2004, 19(9): 650-657.
  • 7Jansen FE, Braams O, Vincken KL, et al. Overlapping neurological and cognitive phenotypes in patients with TSC1 or TSC2 mutation [J]. Neurology, 2008, 70(12): 908-915.
  • 8Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex[J]. Epilepsia, 2009, 51 (7): 1236-1241.
  • 9Jansen FE, Vincken KL, Algra A, tuberous sclerosis complex is a Neurology, 2008, 70(12): 916-923.
  • 10et al. Cognitive impairment in multifactorial condition [J]. Samir H, Ghaffar HA, Nasr M. Seizures and intellectual outcome: clinico-radiological study of 30 Egyptian cases of tuberous sclerosis complex[J]. Eur J Paediatr Neurol, 2010, 15(2): 131-137.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部